Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Eklund

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
The Lancet. Oncology|June 14, 2024
Artificial intelligence for scoring prostate MRI: ready for prospective evaluationMartin Eklund
Lakartidningen|January 12, 2022
Tobias Nordström, Martin Eklund
Nature Reviews. Clinical Oncology|November 6, 2013
Screening: biology dictates the fate of young women with breast cancerMartin Eklund, Laura J Esserman
Nature Reviews. Urology|November 20, 2024
Tomorrow's patient management: LLMs empowered by external toolsKelvin Szolnoky, Tobias Nordström, Martin Eklund
European Urology|October 3, 2018
Towards Next-generation Urine-based Prostate Cancer Risk StratificationTobias Nordström, Johan Lindberg, Martin Eklund
BMJ (Clinical Research Ed.)|February 3, 2016
Detection of ductal carcinoma in situ and subsequent interval cancersYiwey Shieh, Martin Eklund, Laura Esserman
JAMA Oncology|October 13, 2022
Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific Mortality-ReplyLars Björnebo, Martin Eklund, Anna Lantz
The New England Journal of Medicine|November 24, 2021
MRI-Targeted Biopsy in Prostate Cancer Screening. ReplyMartin Eklund, Andrea Discacciati, Tobias Nordström
Nature Reviews. Clinical Oncology|May 11, 2016
The STHLM3 prostate cancer diagnostic study: calibration, clarification, and commentsMartin Eklund, Henrik Grönberg, Tobias Nordström
World Journal of Urology|August 4, 2016
Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study-Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7Tobias Nordström, Martin Eklund, Henrik Grönberg
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
The Lancet. Oncology|June 14, 2024
Artificial intelligence for scoring prostate MRI: ready for prospective evaluationMartin Eklund
Lakartidningen|January 12, 2022
Tobias Nordström, Martin Eklund
Nature Reviews. Clinical Oncology|November 6, 2013
Screening: biology dictates the fate of young women with breast cancerMartin Eklund, Laura J Esserman
Nature Reviews. Urology|November 20, 2024
Tomorrow's patient management: LLMs empowered by external toolsKelvin Szolnoky, Tobias Nordström, Martin Eklund
European Urology|October 3, 2018
Towards Next-generation Urine-based Prostate Cancer Risk StratificationTobias Nordström, Johan Lindberg, Martin Eklund
BMJ (Clinical Research Ed.)|February 3, 2016
Detection of ductal carcinoma in situ and subsequent interval cancersYiwey Shieh, Martin Eklund, Laura Esserman
JAMA Oncology|October 13, 2022
Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific Mortality-ReplyLars Björnebo, Martin Eklund, Anna Lantz
The New England Journal of Medicine|November 24, 2021
MRI-Targeted Biopsy in Prostate Cancer Screening. ReplyMartin Eklund, Andrea Discacciati, Tobias Nordström
Nature Reviews. Clinical Oncology|May 11, 2016
The STHLM3 prostate cancer diagnostic study: calibration, clarification, and commentsMartin Eklund, Henrik Grönberg, Tobias Nordström
World Journal of Urology|August 4, 2016
Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study-Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7Tobias Nordström, Martin Eklund, Henrik Grönberg
Pageof 21